Evidence map›Paper›PMID 28191440›Full record

ReviewNano convergence2016

Current achievements of nanoparticle applications in developing optical sensing and imaging techniques.

Jong-Ryul Choi, Dong-Myeong Shin, Hyerin Song, Donghoon Lee, Kyujung Kim

Abstract readReview
In one paragraph

Review in Nano convergence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Ligand Decomposition during Nanoparticle Synthesis: Influence of Ligand Structure and Precursor Selection.Chemistry of materials : a publication of the American Chemical Society · 2023
    Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jong-Ryul Choi *Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, 41061 Republic of Korea.
Dong-Myeong Shin *Research Center for Energy Convergence Technology, Pusan National University, Busan, 46241 Republic of Korea.
Hyerin SongDepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan, 46241 Republic of Korea.
Donghoon LeeDepartment of Psychology, Pusan National University, Busan, 46241 Republic of Korea.
Kyujung KimDepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan, 46241 Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metallic nanostructures have recently been demonstrated to improve the performance of optical sensing and imaging techniques due to their remarkable localization capability of electromagnetic fields. Particularly, the zero-dimensional nanostructure, commonly called a nanoparticle, is a promising component for optical measurement systems due to its attractive features, e.g., ease of fabrication, capability of surface modification and relatively high biocompatibility. This review summarizes the work to date on metallic nanoparticles for optical sensing and imaging applications, starting with the theoretical backgrounds of plasmonic effects in nanoparticles and moving through the applications in Raman spectroscopy and fluorescence biosensors. Various efforts for enhancing the sensitivity, selectivity and biocompatibility are summarized, and the future outlooks for this field are discussed. Convergent studies in optical sensing and imaging have been emerging field for the development of medical applications, including clinical diagnosis and therapeutic applications.

Indexed as

Field localizationNanoparticlesOptical imagingOptical sensingSurface plasmons

Identifiers

PMID28191440
PMCPMC5271156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.